| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |